148 related articles for article (PubMed ID: 21764212)
1. Prostate derived ETS factor (PDEF): a putative tumor metastasis suppressor.
Steffan JJ; Koul HK
Cancer Lett; 2011 Nov; 310(1):109-17. PubMed ID: 21764212
[TBL] [Abstract][Full Text] [Related]
2. PDEF in prostate cancer.
Sood AK; Kim H; Geradts J
Prostate; 2012 May; 72(6):592-6. PubMed ID: 21796651
[TBL] [Abstract][Full Text] [Related]
3. Prostate epithelium-derived Ets transcription factor mRNA is overexpressed in human breast tumors and is a candidate breast tumor marker and a breast tumor antigen.
Ghadersohi A; Sood AK
Clin Cancer Res; 2001 Sep; 7(9):2731-8. PubMed ID: 11555586
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
[TBL] [Abstract][Full Text] [Related]
5. PDEF downregulates stathmin expression in prostate cancer.
Sabherwal Y; Mahajan N; Helseth DL; Gassmann M; Shi H; Zhang M
Int J Oncol; 2012 Jun; 40(6):1889-99. PubMed ID: 22378487
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of a PDEF Ets transcription factor-interacting protein complex.
Cho JY; Lee M; Ahn JM; Park ES; Cho JH; Lee SJ; Kim BG; Heo SH; Park HJ; Zerbini LF; Hwang D; Libermann TA
J Proteome Res; 2009 Mar; 8(3):1327-37. PubMed ID: 19203193
[TBL] [Abstract][Full Text] [Related]
7. Prostate-derived ETS factor is a mediator of metastatic potential through the inhibition of migration and invasion in breast cancer.
Turner DP; Moussa O; Sauane M; Fisher PB; Watson DK
Cancer Res; 2007 Feb; 67(4):1618-25. PubMed ID: 17308102
[TBL] [Abstract][Full Text] [Related]
8. Silibinin down-regulates prostate epithelium-derived Ets transcription factor in LNCaP prostate cancer cells.
Thelen P; Jarry H; Ringert RH; Wuttke W
Planta Med; 2004 May; 70(5):397-400. PubMed ID: 15124082
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic modifications of prostate-derived Ets transcription factor in breast cancer cells.
Sabherwal Y; Mahajan N; Zhang M
Oncol Rep; 2013 Oct; 30(4):1985-8. PubMed ID: 23921628
[TBL] [Abstract][Full Text] [Related]
10. Pdef expression in human breast cancer is correlated with invasive potential and altered gene expression.
Feldman RJ; Sementchenko VI; Gayed M; Fraig MM; Watson DK
Cancer Res; 2003 Aug; 63(15):4626-31. PubMed ID: 12907642
[TBL] [Abstract][Full Text] [Related]
11. Signatures of prostate-derived Ets factor (PDEF) in cancer.
Mahajan N
Tumour Biol; 2016 Nov; 37(11):14335-14340. PubMed ID: 27612480
[TBL] [Abstract][Full Text] [Related]
12. NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter.
Chen H; Nandi AK; Li X; Bieberich CJ
Cancer Res; 2002 Jan; 62(2):338-40. PubMed ID: 11809674
[TBL] [Abstract][Full Text] [Related]
13. Tumor metastasis suppressor functions of Ets transcription factor through integrin β3-mediated signaling pathway.
Pal M
J Cell Physiol; 2019 Nov; 234(11):20266-20274. PubMed ID: 30982973
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Derived Ets Factor (PDEF) Inhibits Metastasis by Inducing Epithelial/Luminal Phenotype in Prostate Cancer Cells.
Wang F; Koul S; Shanmugam PST; Dong Q; Koul HK
Mol Cancer Res; 2018 Sep; 16(9):1430-1440. PubMed ID: 29848555
[TBL] [Abstract][Full Text] [Related]
15. Reduced PDEF expression increases invasion and expression of mesenchymal genes in prostate cancer cells.
Gu X; Zerbini LF; Otu HH; Bhasin M; Yang Q; Joseph MG; Grall F; Onatunde T; Correa RG; Libermann TA
Cancer Res; 2007 May; 67(9):4219-26. PubMed ID: 17483333
[TBL] [Abstract][Full Text] [Related]
16. Prostate derived Ets transcription factor shows better tumor-association than other cancer-associated molecules.
Ghadersohi A; Odunsi K; Lele S; Collins Y; Greco WR; Winston J; Liang P; Sood AK
Oncol Rep; 2004 Feb; 11(2):453-8. PubMed ID: 14719083
[TBL] [Abstract][Full Text] [Related]
17. Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells.
Tsui KH; Lin YH; Chung LC; Chuang ST; Feng TH; Chiang KC; Chang PL; Yeh CJ; Juang HH
Cancer Lett; 2016 May; 375(1):142-151. PubMed ID: 26965996
[TBL] [Abstract][Full Text] [Related]
18. Prostate-derived Ets factor is overexpressed in serous epithelial ovarian tumors.
Rodabaugh KJ; Mhawech-Fauceglia P; Groth J; Lele S; Sood AK
Int J Gynecol Pathol; 2007 Jan; 26(1):10-5. PubMed ID: 17197890
[TBL] [Abstract][Full Text] [Related]
19. Expression characteristics of prostate-derived Ets factor support a role in breast and prostate cancer progression.
Sood AK; Saxena R; Groth J; Desouki MM; Cheewakriangkrai C; Rodabaugh KJ; Kasyapa CS; Geradts J
Hum Pathol; 2007 Nov; 38(11):1628-38. PubMed ID: 17521701
[TBL] [Abstract][Full Text] [Related]
20. AR-PDEF pathway promotes tumour proliferation and upregulates MYC-mediated gene transcription by promoting MAD1 degradation in ER-negative breast cancer.
Cao L; Xu C; Xiang G; Liu F; Liu X; Li C; Liu J; Meng Q; Jiao J; Niu Y
Mol Cancer; 2018 Sep; 17(1):136. PubMed ID: 30217192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
